Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML)

Summary

The goal of this clinical study is to find out whether continued therapy with decitabine after achieving a remission in acute myeloid leukemia (AML) patients can help prolong the remission and prevent relapse of the disease.

Timeline

Start

2006-08

Primary completion

2012-05

Completion

2012-05

Drugs

Indications